Shu, Mengjun
Gao, Feng
Yu, Chulang
Zeng, Min
He, Guili
Wu, Yan
Su, Yanjie
Hu, Nantao
Zhou, Zhihua
Yang, Zhi
Xu, Lin
Funding for this research was provided by:
Medical-Engineering Crossover Fund of SJTU (YG2016MS26)
National Natural Science Foundation of China (21171117)
Article Title: Dual-targeted therapy in HER2-positive breast cancer cells with the combination of carbon dots/HER3 siRNA and trastuzumab
Journal Title: Nanotechnology
Article Type: paper
Copyright Information: © 2020 IOP Publishing Ltd. All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Publication dates
Date Received: 2019-11-20
Date Accepted: 2020-04-17
Online publication date: 2020-05-28